SK
Therapeutic Areas
Inventprise Pipeline
| Drug | Indication | Phase |
|---|---|---|
| IVT PCV-25 | Pediatric Pneumococcal Disease | Not Disclosed (Likely Preclinical/Phase 1) |
| IVT GBS-06 | Group B Streptococcus | Phase 1/2 |
| Shigella Vaccine | Shigellosis | Not Disclosed |
| Klebsiella Vaccine | Klebsiella pneumoniae Infection | Not Disclosed |
| COVID-19 Conjugate Vaccine | COVID-19 | Not Disclosed (Research/Preclinical) |